ESR1 and neoplasm: Tissue staining with antibodies against estrogen receptor alpha (ERα), a marker for common luminal-like tumor subtypes, demonstrated that CAGMYC MECcomprised malignant lesions with positive ERα receptor nuclear staining, supporting their luminal-like classification (Fig. 2e and Supplementary Fig. 3c).